December 10, 2014 — In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
December 9, 2014 — CardioKinetix Inc. announced it has completed a $50 million financing led by Edwards Lifesciences ...
December 9, 2014 — A study published in the Journal of the American College of Cardiology (JACC) shows intravascular ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
December 4, 2014 — Covidien announced that it received U.S. Food and Drug Administration 510(k) clearance for its Fortre ...
December 2, 2014 – Results of a new study challenge the current consensus in cardiology that peak myocardial edema only ...
December 4, 2014 — Biodex showcased its latest line of medical imaging tables and Clear-Lead Shielding at RSNA 2014.
...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 30, 2014 — At this year’s RSNA annual meeting, Ziehm Imaging will highlight Ziehm Vision RFD 3-D, a 3-D C-arm ...
November 26, 2014 — CompView Medical (CVM) debuts the M2u and M4u, its latest design of NuBOOM, an all-in-one equipment ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 21, 2014 — A coordinated emergency response by healthcare teams to treat heart attack patients meant faster ...
November 17, 2014 — VIVA Physicians, a not-for-profit organization in the field of vascular medicine and intervention ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
Nov. 14, 2014 — Covidien releases 12-month results of the DEFINITIVE AR study, the first randomized study designed to ...
Nov. 14, 2014 — Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable ...
Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations ...